€50-70k
+ Stock Options
Medical platform for chronic skin conditions
Open for applications
Medical platform for chronic skin conditions
21-100 employees
Open for applications
€50-70k
+ Stock Options
21-100 employees
To provide a highly engaging and personalised patient experience that removes barriers to health behaviour change.
Jump to section
To provide a highly engaging and personalised patient experience that removes barriers to health behaviour change.
Currently being used in five European clinical studies, Nia Health is a digital medical platform geared towards those suffering from chronic skin conditions such as neurodermatitis. Through digital therapeutics and consultations, Nia also aids in the monitoring of patients and treatments through industry data analysis, which can be leveraged by businesses as well as patients.
This multi-pronged solution to chronic skin conditions has drawn major investment from Biomed investors such as Ventura and the Berlin University of Medicine. In response, Nia has been scaling up its operations throughout the EU.
The investment will be used to lay the groundwork for US market entry, something that it is primed for after partnering with the likes of Sanofi and Pfizer since its founding in 2019. With revenue doubling between 2021 and 2022, Nia is on the right path for continued growth.
Steph
Company Specialist at Welcome to the Jungle
May 2023
$3.7m
SEED
Jun 2020
$0.1m
GRANT
Tobias Seidl
(CEO)Previously Recipient of the EXIST Scholarship, CEO of Biodirekt GmbH, Head of Business Development at Rocket Internet SE and a Consultant at Kienbaum.
Oliver Welter
(CTO)Previously Receipient of EXIST Business Start-Up Grant, CTO at caresyntax, Software Architect at GfK nurago GmbH and Senior Software Engineer at PPI AG.
Dr. Reem Alneebari
(Chief Medical Officer)Currently Senior Medical Advisor at MedGroup LLC. Previously Recipient of the Fellowship Aesthetic Laser Medicine DALM from Ernst-Moritz-Arndt-Universität Greifswald and Dermatologist at Praxis Dres.